Full Committee

Tackling the Opioid Crisis: A Whole-of-Government Approach

Type: Full Committee Hearing

Date: Tuesday, December 17th, 2019

Time: 10:00am

Location: Dirksen Senate Office Building 226

Presiding: Senator Ernst

Panel I

Mr. Kemp ChesterAssistant Director of the National Opioids and Synthetics Coordination GroupOffice of National Drug Control PolicyWashington, DC

Download Testimony
Ms. Amanda LiskammDirector of Opioid Enforcement and Prevention EffortsOffice of the Deputy Attorney GeneralU.S. Department of Justice Washington, DC

Download Testimony

Download Responses to Questions for the Record
Mr. William T. McDermottAssistant AdministratorDiversion Control DivisionDrug Enforcement AdministrationArlington, VA

Download Testimony

Download Responses to Questions for the Record
Neeraj Gandotra, M.D.

Chief Medical Officer

Substance Abuse And Mental Health Services Administration Department of Health and Human Services

Rockville, MD

Download Testimony

Bradley D. Stein M.D., Ph.D.

Senior Physician Policy Researcher

RAND Corporation

Pittsburgh, PA

Download Testimony

Download Responses to Questions for the Record
Mr. Patrick M. KellyExecutive Vice PresidentGovernment AffairsHealthcare Distribution AllianceArlington, VA

Download Testimony

Kelly Responses to Questions for the Record
Dr. Ronna B. Hauser, Pharm.DVice PresidentPolicy and Regulatory Affairs National Community Pharmacists AssociationAlexandria, VA

Download Testimony

Download Responses to Questions for the Record
Sue Thau

Public Policy Consultant

Community Anti-Drug Coalitions of America

Alexandria, VA

Download Testimony

Download Responses to Questions for the Record